Colon Cancer
News
Colon Cancer Outcomes Differ Between Men and Women
(05/09/2008)
Variations within the gene responsible for epidermal growth factor receptors (EGFR) may be predictive of differing outcomes between male and female patients diagnosed with metastatic colon cancer. Details of the study have recently been published in the Journal of Cancer Research.
Changes in Lifestyle May Improve Quality of Life for Colon Cancer Survivors
(05/07/2008)
A recent study conducted by the American Cancer Society reports that although few cancer survivors follow recommendations for lifestyle changes aimed to improve health and well-being, adhering to these guidelines may improve quality of life among colon cancer survivors. Full details of the study were recently published in the Journal of Clinical Oncology.
Physicians with More Training Perform More Effective Colonoscopies
(05/07/2008)
A recent trial conducted at 15 different medical centers in Korea indicates that a physician must perform at least 150 colonoscopies to be considered competent at the procedure. Details of the study were recently published in the journal Gastrointestinal Endoscopy.
Celebrex® Reduces Colon Adenomas
(04/17/2008)
The COX2-inhibitor Celebrex® (celecoxib) reduces the rate of colon adenomas at five years and appears safe, even among patients with cardiovascular disease. These results were recently presented as a late-breaking abstract at the 2008 annual meeting of the American Association for Cancer Research.
Drug Combination Decreases Recurrence Rate of Colon Polyps
(04/15/2008)
The combination of the difluoromethylornithine (DFMO) and sulindac reduces the rate of colon adenomas (growths or polyps) by up to 95% among patients who have had prior colon polyps. These results were presented as a late-breaking abstract at the 2008 annual meeting of the American Association for Cancer Research.
More
Colon Cancer
Cancer News...